|
1
|
Feng D, Peng C, Li C, Zhou Y, Li M, Ling
B, Wei H and Tian Z: Identification and characterization of cancer
stem-like cells from primary carcinoma of the cervix uteri. Oncol
Rep. 22:1129–1134. 2009.PubMed/NCBI
|
|
2
|
Bortolomai I, Canevari S, Facetti I, De
Cecco L, Castellano G, Zacchetti A, Alison MR and Miotti S: Tumor
initiating cells: development and critical characterization of a
model derived from the A431 carcinoma cell line forming spheres in
suspension. Cell Cycle. 9:1194–1206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song L, Turkson J, Karras JG, Jove R and
Haura EB: Activation of Stat3 by receptor tyrosine kinases and
cytokines regulates survival in human non-small cell carcinoma
cells. Oncogene. 22:4150–4165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang P, Li H, Yang B, Yang F, Zhang LL,
Kong QY, Chen XY, Wu ML and Liu J: Biological significance and
therapeutic implication of resveratrol-inhibited Wnt, Notch and
STAT3 signaling in cervical cancer cells. Genes Cancer. 5:154–164.
2014.PubMed/NCBI
|
|
6
|
Kruczyk M, Przanowski P, Dabrowski M,
Swiatek-Machado K, Mieczkowski J, Wallerman O, Ronowicz A,
Piotrowski A, Wadelius C, Kaminska B and Komorowski J: Integration
of genome-wide of Stat3 binding and epigenetic modification mapping
with transcriptome reveals novel Stat3 target genes in glioma
cells. Biochim Biophys Acta. 1839:1341–1350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao J, Qian CJ, Ye B, Zhao ZQ, Wei J,
Liang Y and Zhang X: Signal transducer and activator of
transcription 3 signaling upregulates fascin via nuclear factor-κB
in gastric cancer: Implications in cell invasion and migration.
Oncol Lett. 7:902–908. 2014.PubMed/NCBI
|
|
8
|
Bao W, Wang HH, Tian FJ, He XY, Qiu MT,
Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-miR-204-5p
regulatory circuitry controls proliferation and invasion of
endometrial carcinoma cells. Mol Cancer. 12:1552013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola
D, Mansour M, Xu LM, Costanzo C, Cheng JQ and Wang LH: Twist is
transcriptionally induced by activation of STAT3 and mediates STAT3
oncogenic function. J Biol Chem. 283:14665–14673. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qin A, Yu Q, Gao Y, Tan J, Huang H, Qiao Z
and Qian W: Inhibition of STAT3/cyclinD1 pathway promotes
chemotherapeutic sensitivity of colorectal caner. Biochem Biophys
Res Commun. 457:681–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takemoto S, Ushijima K, Kawano K,
Yamaguchi T, Terada A, Fujiyoshi N, Nishio S, Tsuda N, Ijichi M,
Kakuma T, et al: Expression of activated signal transducer and
activator of transcription-3 predicts poor prognosis in cervical
squamous-cell carcinoma. Br J Cancer. 101:967–972. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Devarajan E and Huang S: STAT3 as a
central regulator of tumor metastases. Curr Mol Med. 9:626–633.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao C, Zhao G, Yu W, Xie X, Wang W, Yang
R, Lv X and Liu D: Activation of STAT3 stimulates AHSP expression
in K562 cells. Sci China Life Sci. 57:488–494. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye F, Zhou C, Cheng Q, Shen J and Chen H:
Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are
highly expressed in malignant cervical epithelial cells. BMC
Cancer. 8:1082008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsai LL, Yu CC, Chang YC, Yu CH and Chou
MY: Markedly increased Oct4 and Nanog expression correlates with
cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol
Med. 40:621–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Oron E, Nelson B, Razis S and
Ivanova N: Distinct lineage specification roles for NANOG, OCT4,
and SOX2 in human embryonic stem cells. Cell Stem Cell. 10:440–454.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu XF, Yang WT, Xu R, Liu JT and Zheng
PS: Cervical cancer cells with positive Sox2 expression exhibit the
properties of cancer stem cells. PLoS One. 28:870–892. 2014.
|
|
20
|
Li SW, Wu XL, Dong CL, Xie XY, Wu JF and
Zhang X: The differential expression of OCT4 isoforms in cervical
carcinoma. PLoS One. 10:e01180332015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bourguignon LY, Peyrollier K, Xia W and
Gilad E: Hyaluronan-CD44 interaction activates stem cell marker
Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated
multidrug efflux in breast and ovarian tumor cells. J Biol Chem.
283:17635–17651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Do DV, Ueda J, Messerschmidt DM,
Lorthongpanich C, Zhou Y, Feng B, Guo G, Lin PJ, Hossain MZ, Zhang
W, et al: A genetic and developmental pathway from STAT3 to the
OCT4-NANOG circuit is essential for maintenance of ICM lineages in
vivo. Genes Dev. 27:1378–1390. 2013. View Article : Google Scholar : PubMed/NCBI
|
